vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Intellicheck, Inc. (IDN). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $6.6M, roughly 1.2× Intellicheck, Inc.). Intellicheck, Inc. runs the higher net margin — 23.4% vs -48.7%, a 72.1% gap on every dollar of revenue. On growth, Intellicheck, Inc. posted the faster year-over-year revenue change (11.8% vs -2.3%). Intellicheck, Inc. produced more free cash flow last quarter ($2.4M vs $1.2M). Over the past eight quarters, Intellicheck, Inc.'s revenue compounded faster (19.1% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Intellicheck, Inc. is a US-based technology company specializing in identity verification and fraud prevention solutions. It develops AI-powered tools to validate government-issued identification documents, streamline customer onboarding, and mitigate identity theft risks for clients across finance, retail, healthcare and public sector segments.

CCEL vs IDN — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.2× larger
CCEL
$7.8M
$6.6M
IDN
Growing faster (revenue YoY)
IDN
IDN
+14.0% gap
IDN
11.8%
-2.3%
CCEL
Higher net margin
IDN
IDN
72.1% more per $
IDN
23.4%
-48.7%
CCEL
More free cash flow
IDN
IDN
$1.2M more FCF
IDN
$2.4M
$1.2M
CCEL
Faster 2-yr revenue CAGR
IDN
IDN
Annualised
IDN
19.1%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
IDN
IDN
Revenue
$7.8M
$6.6M
Net Profit
$-3.8M
$1.6M
Gross Margin
77.9%
91.4%
Operating Margin
-50.6%
22.5%
Net Margin
-48.7%
23.4%
Revenue YoY
-2.3%
11.8%
Net Profit YoY
-105.1%
218.0%
EPS (diluted)
$-0.46
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
IDN
IDN
Q4 25
$7.8M
$6.6M
Q3 25
$7.8M
$6.0M
Q2 25
$7.9M
$5.1M
Q1 25
$8.0M
$4.9M
Q4 24
$8.0M
$5.9M
Q3 24
$8.1M
$4.7M
Q2 24
$8.0M
$4.7M
Q1 24
$7.9M
$4.7M
Net Profit
CCEL
CCEL
IDN
IDN
Q4 25
$-3.8M
$1.6M
Q3 25
$749.4K
$290.0K
Q2 25
$355.8K
$-251.0K
Q1 25
$282.9K
$-318.0K
Q4 24
$-1.9M
$488.0K
Q3 24
$1.1M
$-837.0K
Q2 24
$655.8K
$-127.0K
Q1 24
$556.2K
$-442.0K
Gross Margin
CCEL
CCEL
IDN
IDN
Q4 25
77.9%
91.4%
Q3 25
77.0%
90.5%
Q2 25
76.6%
89.8%
Q1 25
75.1%
89.7%
Q4 24
78.4%
91.1%
Q3 24
73.6%
91.0%
Q2 24
74.8%
90.5%
Q1 24
73.7%
90.7%
Operating Margin
CCEL
CCEL
IDN
IDN
Q4 25
-50.6%
22.5%
Q3 25
24.3%
4.0%
Q2 25
18.8%
-5.8%
Q1 25
13.3%
-7.1%
Q4 24
-1.5%
8.1%
Q3 24
17.2%
-19.3%
Q2 24
17.3%
-4.6%
Q1 24
10.5%
-11.2%
Net Margin
CCEL
CCEL
IDN
IDN
Q4 25
-48.7%
23.4%
Q3 25
9.6%
4.8%
Q2 25
4.5%
-4.9%
Q1 25
3.5%
-6.5%
Q4 24
-23.2%
8.2%
Q3 24
13.0%
-17.8%
Q2 24
8.2%
-2.7%
Q1 24
7.1%
-9.4%
EPS (diluted)
CCEL
CCEL
IDN
IDN
Q4 25
$-0.46
$0.08
Q3 25
$0.09
$0.01
Q2 25
$0.04
$-0.01
Q1 25
$0.03
$-0.02
Q4 24
$-0.23
$0.02
Q3 24
$0.13
$-0.04
Q2 24
$0.08
$-0.01
Q1 24
$0.07
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
IDN
IDN
Cash + ST InvestmentsLiquidity on hand
$3.3M
$9.7M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$20.7M
Total Assets
$61.7M
$24.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
IDN
IDN
Q4 25
$3.3M
$9.7M
Q3 25
$3.2M
$7.2M
Q2 25
$4.4M
$8.6M
Q1 25
$3.5M
$5.1M
Q4 24
$3.5M
$4.7M
Q3 24
$2.1M
$5.7M
Q2 24
$1.5M
$7.3M
Q1 24
$979.6K
$9.2M
Total Debt
CCEL
CCEL
IDN
IDN
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
IDN
IDN
Q4 25
$-18.6M
$20.7M
Q3 25
$-14.8M
$18.9M
Q2 25
$-15.6M
$18.0M
Q1 25
$-14.7M
$17.6M
Q4 24
$-13.2M
$17.7M
Q3 24
$-9.6M
$16.7M
Q2 24
$-10.7M
$17.3M
Q1 24
$-10.3M
$17.2M
Total Assets
CCEL
CCEL
IDN
IDN
Q4 25
$61.7M
$24.5M
Q3 25
$63.2M
$25.3M
Q2 25
$64.4M
$23.1M
Q1 25
$64.4M
$24.6M
Q4 24
$64.7M
$20.9M
Q3 24
$62.9M
$20.7M
Q2 24
$62.6M
$21.9M
Q1 24
$61.7M
$22.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
IDN
IDN
Operating Cash FlowLast quarter
$1.3M
$2.4M
Free Cash FlowOCF − Capex
$1.2M
$2.4M
FCF MarginFCF / Revenue
15.5%
36.0%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
1.54×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
IDN
IDN
Q4 25
$1.3M
$2.4M
Q3 25
$2.5M
$-1.7M
Q2 25
$707.0K
$3.1M
Q1 25
$954.1K
$750.0K
Q4 24
$2.2M
$-1.3M
Q3 24
$2.4M
$-1.1M
Q2 24
$1.8M
$-1.2M
Q1 24
$-356.9K
$869.0K
Free Cash Flow
CCEL
CCEL
IDN
IDN
Q4 25
$1.2M
$2.4M
Q3 25
$2.5M
$-1.8M
Q2 25
$644.6K
$3.1M
Q1 25
$892.0K
$741.0K
Q4 24
$2.1M
$-1.3M
Q3 24
$2.3M
$-1.1M
Q2 24
$21.5K
$-1.2M
Q1 24
$-814.6K
$860.0K
FCF Margin
CCEL
CCEL
IDN
IDN
Q4 25
15.5%
36.0%
Q3 25
31.9%
-29.2%
Q2 25
8.1%
60.9%
Q1 25
11.2%
15.1%
Q4 24
26.8%
-22.4%
Q3 24
27.9%
-23.1%
Q2 24
0.3%
-25.5%
Q1 24
-10.4%
18.4%
Capex Intensity
CCEL
CCEL
IDN
IDN
Q4 25
0.9%
0.1%
Q3 25
0.5%
0.4%
Q2 25
0.8%
0.3%
Q1 25
0.8%
0.2%
Q4 24
0.1%
0.2%
Q3 24
2.3%
0.6%
Q2 24
21.8%
0.2%
Q1 24
5.8%
0.2%
Cash Conversion
CCEL
CCEL
IDN
IDN
Q4 25
1.54×
Q3 25
3.38×
-5.99×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
-2.71×
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons